415 related articles for article (PubMed ID: 12917692)
1. Rationalization of the effects of mutations on peptide and protein aggregation rates.
Chiti F; Stefani M; Taddei N; Ramponi G; Dobson CM
Nature; 2003 Aug; 424(6950):805-8. PubMed ID: 12917692
[TBL] [Abstract][Full Text] [Related]
2. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases.
Chiti F; Calamai M; Taddei N; Stefani M; Ramponi G; Dobson CM
Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16419-26. PubMed ID: 12374855
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains.
DuBay KF; Pawar AP; Chiti F; Zurdo J; Dobson CM; Vendruscolo M
J Mol Biol; 2004 Aug; 341(5):1317-26. PubMed ID: 15302561
[TBL] [Abstract][Full Text] [Related]
4. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.
Fernandez-Escamilla AM; Rousseau F; Schymkowitz J; Serrano L
Nat Biotechnol; 2004 Oct; 22(10):1302-6. PubMed ID: 15361882
[TBL] [Abstract][Full Text] [Related]
5. Protein misfolding, functional amyloid, and human disease.
Chiti F; Dobson CM
Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495
[TBL] [Abstract][Full Text] [Related]
6. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
[TBL] [Abstract][Full Text] [Related]
7. Protein folding and misfolding.
Dobson CM
Nature; 2003 Dec; 426(6968):884-90. PubMed ID: 14685248
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Cohen SI; Linse S; Luheshi LM; Hellstrand E; White DA; Rajah L; Otzen DE; Vendruscolo M; Dobson CM; Knowles TP
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9758-63. PubMed ID: 23703910
[TBL] [Abstract][Full Text] [Related]
9. Prediction of aggregation-prone regions in structured proteins.
Tartaglia GG; Pawar AP; Campioni S; Dobson CM; Chiti F; Vendruscolo M
J Mol Biol; 2008 Jul; 380(2):425-36. PubMed ID: 18514226
[TBL] [Abstract][Full Text] [Related]
10. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.
Stefani M; Dobson CM
J Mol Med (Berl); 2003 Nov; 81(11):678-99. PubMed ID: 12942175
[TBL] [Abstract][Full Text] [Related]
11. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.
Petkova AT; Leapman RD; Guo Z; Yau WM; Mattson MP; Tycko R
Science; 2005 Jan; 307(5707):262-5. PubMed ID: 15653506
[TBL] [Abstract][Full Text] [Related]
12. Predicting aggregation-prone sequences in proteins.
De Baets G; Schymkowitz J; Rousseau F
Essays Biochem; 2014; 56():41-52. PubMed ID: 25131585
[TBL] [Abstract][Full Text] [Related]
13. Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes.
Castillo V; Graña-Montes R; Sabate R; Ventura S
Biotechnol J; 2011 Jun; 6(6):674-85. PubMed ID: 21538897
[TBL] [Abstract][Full Text] [Related]
14. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
Chiti F; Dobson CM
Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
[TBL] [Abstract][Full Text] [Related]
15. The Zyggregator method for predicting protein aggregation propensities.
Tartaglia GG; Vendruscolo M
Chem Soc Rev; 2008 Jul; 37(7):1395-401. PubMed ID: 18568165
[TBL] [Abstract][Full Text] [Related]
16. Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils.
Colvin MT; Silvers R; Ni QZ; Can TV; Sergeyev I; Rosay M; Donovan KJ; Michael B; Wall J; Linse S; Griffin RG
J Am Chem Soc; 2016 Aug; 138(30):9663-74. PubMed ID: 27355699
[TBL] [Abstract][Full Text] [Related]
17. Prediction of amyloid aggregation in vivo.
Belli M; Ramazzotti M; Chiti F
EMBO Rep; 2011 Jul; 12(7):657-63. PubMed ID: 21681200
[TBL] [Abstract][Full Text] [Related]
18. The amyloid state and its association with protein misfolding diseases.
Knowles TP; Vendruscolo M; Dobson CM
Nat Rev Mol Cell Biol; 2014 Jun; 15(6):384-96. PubMed ID: 24854788
[TBL] [Abstract][Full Text] [Related]
19. In silico cross seeding of Aβ and amylin fibril-like oligomers.
Berhanu WM; Yaşar F; Hansmann UH
ACS Chem Neurosci; 2013 Nov; 4(11):1488-500. PubMed ID: 24007594
[TBL] [Abstract][Full Text] [Related]
20. Probing aromatic, hydrophobic, and steric effects on the self-assembly of an amyloid-β fragment peptide.
Senguen FT; Lee NR; Gu X; Ryan DM; Doran TM; Anderson EA; Nilsson BL
Mol Biosyst; 2011 Feb; 7(2):486-96. PubMed ID: 21060949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
